Ropeginterferon alfa-2b Alternatives Compared
| Ropeginterferon alfa-2b | Hydroxyurea | Jakafi (ruxolitinib) |
|
|---|
| Ropeginterferon alfa-2b | Hydroxyurea | Jakafi (ruxolitinib) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Polycythemia Vera. Ropeginterferon alfa-2b may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Myelogenous Leukemia, Sickle Cell Anemia, Cervical Cancer, Head and Neck Cancer, Glioblastoma Multiforme, Plaque Psoriasis, Polycythemia Vera, Psoriasis, Psoriatic Arthritis... View more |
Prescription only
Prescribed for Polycythemia Vera, Myelofibrosis, Graft Versus Host Disease, Myeloproliferative Disorders. Jakafi may also be used for purposes not listed in this medication guide. |
Related suggestions Polycythemia Vera
|
|||||||||||||||
| More about Ropeginterferon alfa-2b | More about Hydroxyurea | More about Jakafi (ruxolitinib) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Ropeginterferon alfa-2b has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Hydroxyurea has an average rating of 7.0 out of 10 from a total of 46 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 22% reported a negative effect. |
Jakafi has an average rating of 7.4 out of 10 from a total of 33 ratings on Drugs.com. 66% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Hydroxyurea prices |
View all Jakafi prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Besremi | Droxia, Hydrea, Siklos, Xromi |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
240 hours |
4 hours |
5.8 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 443 drugs are known to interact with Ropeginterferon alfa-2b:
|
A total of 279 drugs are known to interact with Hydroxyurea:
|
A total of 495 drugs are known to interact with Jakafi:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
December 07, 1967 |
November 16, 2011 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.